Delivery Order SPE2DB20D3505-SPE2DB22FU3D9
Award Date 9/14/22
Potential Completion Date 9/15/22
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,984,356 units of hydroxychloroquine 200 mg tablets. The contract, valued at $1,539.32, is a firm fixed-price delivery order with an ultimate completion date of August 30, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,610.31 firm fixed price Delivery Order (SPE2DB23FV6G6) is for the supply of 4,560,694,177 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of April 25, 2023 and does not utilize any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.37 firm-fixed-price delivery order is for the supply of 4,559,118,916 units of 200 mg hydroxychloroquine tablets packaged in 100-count bottles. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FP9K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.32 firm fixed-price delivery order is for the supply of 4,558,528,321 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,565.32 firm fixed-price delivery order is for the supply of 4,562,813,766 units of hydroxychloroquine 200 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of 4,560,256,895 units of hydroxychloroquine 200 mg tablets, priced at a firm fixed price of $2,766.59. The award was made on March 14, 2023, with a completion date of March 15, 2023, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated with any set-aside requirements, indicating open...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,416.50 to Amerisourcebergen Drug Corporation for 200 milligram tablets of hydroxychloroquine. Amerisourcebergen will deliver 100 tablets of the medication to a location in Conshohocken, Pennsylvania by July 18, 2023 in fulfillment of the contract. As a major division of Amerisourcebergen Corporation, the prime contractor will utilize its extensive distribution network to provide this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,358.25 firm-fixed-price delivery order is for 4,560,912,861 tablets of Plaquenil (hydroxychloroquine sulfate 200 mg), a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract has a completion date of May 12, 2023 and was awarded on May 11, 2023. AmerisourceBergen holds a $999,999,999...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,182.82 fixed-price contract is for the delivery of Plaquenil (hydroxychloroquine) 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...